|
|
Gene Symbol |
CCK |
|
Aliases |
- |
|
Entrez Gene ID |
|
|
Gene Name |
Cholecystokinin |
|
Chromosomal Location |
3p22.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the gastrin/cholecystokinin family of proteins. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the peptide hormones cholecystokinin-8, -12, -33, and others. The encoded peptides have been shown to regulate gastric acid secretion and food intake. A sulfated form of cholecystokinin-8 may modulate neuronal activity in the brain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Cholecystokinin, cholecystokinin triacontatriapeptide, prepro-cholecystokinin |
|
Function |
This peptide hormone induces gall bladder contraction and the release of pancreatic enzymes in the gut. Its function in the brain is not clear. Binding to CCK-A receptors stimulates amylase release from the pancreas, binding to CCK-B receptors stimulates gastric acid secretion |
|
|
UniProt |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00918 |
Gastrin |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000436607 |
|
P35318 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Catalepsy |
|
Atonic seizures |
|
Digestive System Diseases |
Gastric ulcer |
|
Cholera Infantum |
|
Liver Diseases |
|
Pancreatitis |
|
Gastrointestinal Diseases |
|
Endocrine System Diseases |
PCOS |
|
Nervous System Diseases |
Seizures |
|
Dyskinesia |
|
Jacksonian Seizure |
|
Psychiatric/Brain disorders |
Manic Disorder |
|
Schizophrenia |
|
|
References |
|
|
Hirschberg A Linden, Naessen S, Stridsberg M, Bystrom B, Holtet J |
Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden. Angelica.Hirschberg@ks.se |
Gynecol Endocrinol. 2004 Aug;19(2):79-87. |
Abstract
Increased amount of abdominal fat and obesity are common in polycystic ovary syndrome (PCOS). A higher prevalence of bulimia nervosa and greater cravings for sweets have also been reported in these patients. The present study aimed to compare meal-related appetite and secretion of the 'satiety peptide' cholecystokinin (CCK) and glucose regulatory hormones in PCOS women and controls. Sixteen pairs of women with PCOS and controls matched for age and body mass index participated in the study. After an overnight fast, blood samples were collected during ingestion of a standardized meal. We determined basal and postprandial blood levels of CCK, insulin, C-peptide, glucagon, cortisol, growth hormone and glucose. Self-ratings of appetite were assessed by a visual analog scale. PCOS women had a significantly lower meal-related CCK response (p < 0.05) with no association with satiety, as in the controls (r = 0.64). There was a tendency to higher ratings of craving for sweets in PCOS women (p = 0.07) but no correlation with insulin, as in the controls (r = 0.50). Within the PCOS group, ratings of craving for sweets were inversely related to testosterone (r = - 0.60) and the CCK response was positively correlated with levels of free testosterone (r = 0.50). We conclude that women with PCOS have reduced postprandial CCK secretion and deranged appetite regulation associated with increased levels of testosterone. Impaired CCK secretion may play a role in the greater frequency of binge eating and overweight in women with PCOS. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|